Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved TICOVAC (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older. TICOVAC is...
The first coronavirus 2019 (COVID-19) vaccine to be considered for emergency approval may be a month away. Pfizer chief executive officer Albert Bourla wrote in an open letter Friday morning that efficacy and safety...